HALOZYME THERAPEUTICS, INC. (HALO)

SEC filing

HALOZYME THERAPEUTICS, INC.

HALO · CIK 1159036

4 · Aug 19, 2026 · Director, PRESIDENT AND CEO Torley Helen sold 60K shares at $104.59/share ($6.3M); exercised options for 120K shares

Director, PRESIDENT AND CEO Torley Helen sold 60K shares at $104.59/share ($6.3M); exercised options for 120K shares

FORM 4

xslF345X06/wk-form4_1787184072.xmlSEC.gov

Graphics and non-inline formats (not embedded below).